Generalizability of predictive versus prognostic indicators from published transcriptomic associations with tumor response to immune checkpoint inhibition
Authors
Bortone, D.Monette, A.
Tschernia, N.
Cogdill, A.
Najjar, Y.
Sweis, R. F.
Valpione, Sara
Wennerberg, E.
Bommareddy, P.
Haymaker, C.
Khan, U.
McGee, H. M.
Park, W.
Sater, H. A.
Spencer, C.
Ascierto, M.
Barsan, V.
Popat, V.
Wells, D.
Vensko, S.
Dexheimer, S.
Thorsson, V.
Zappasodi, R.
Rudqvist, N. P.
Vincent, B.
Affiliation
University of North Carolina at Chapel Hill, Chapel Hill, NCIssue Date
2022
Metadata
Show full item recordCitation
Bortone D, Monette A, Tschernia N, Cogdill A, Najjar Y, Sweis RF, et al. Generalizability of Predictive Versus Prognostic Indicators from Published Transcriptomic Associations with Tumor Response to Immune Checkpoint Inhibition. Journal for immunotherapy of cancer. 2022 Nov;10:A531-A2. PubMed PMID: WOS:000919423400487.Journal
Journal for Immunotherapy of CancerDOI
10.1136/jitc-2022-SITC2022.0508Additional Links
https://dx.doi.org/10.1136/jitc-2022-SITC2022.0508Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1136/jitc-2022-SITC2022.0508